These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 35968817)

  • 1. The Notch signaling pathway in skeletal muscle health and disease.
    Vargas-Franco D; Kalra R; Draper I; Pacak CA; Asakura A; Kang PB
    Muscle Nerve; 2022 Nov; 66(5):530-544. PubMed ID: 35968817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A form of muscular dystrophy associated with pathogenic variants in JAG2.
    Coppens S; Barnard AM; Puusepp S; Pajusalu S; Õunap K; Vargas-Franco D; Bruels CC; Donkervoort S; Pais L; Chao KR; Goodrich JK; England EM; Weisburd B; Ganesh VS; Gudmundsson S; O'Donnell-Luria A; Nigul M; Ilves P; Mohassel P; Siddique T; Milone M; Nicolau S; Maroofian R; Houlden H; Hanna MG; Quinlivan R; Beiraghi Toosi M; Ghayoor Karimiani E; Costagliola S; Deconinck N; Kadhim H; Macke E; Lanpher BC; Klee EW; Łusakowska A; Kostera-Pruszczyk A; Hahn A; Schrank B; Nishino I; Ogasawara M; El Sherif R; Stojkovic T; Nelson I; Bonne G; Cohen E; Boland-Augé A; Deleuze JF; Meng Y; Töpf A; Vilain C; Pacak CA; Rivera-Zengotita ML; Bönnemann CG; Straub V; Handford PA; Draper I; Walter GA; Kang PB
    Am J Hum Genet; 2021 May; 108(5):840-856. PubMed ID: 33861953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss.
    Servián-Morilla E; Takeuchi H; Lee TV; Clarimon J; Mavillard F; Area-Gómez E; Rivas E; Nieto-González JL; Rivero MC; Cabrera-Serrano M; Gómez-Sánchez L; Martínez-López JA; Estrada B; Márquez C; Morgado Y; Suárez-Calvet X; Pita G; Bigot A; Gallardo E; Fernández-Chacón R; Hirano M; Haltiwanger RS; Jafar-Nejad H; Paradas C
    EMBO Mol Med; 2016 Nov; 8(11):1289-1309. PubMed ID: 27807076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern.
    Servián-Morilla E; Cabrera-Serrano M; Johnson K; Pandey A; Ito A; Rivas E; Chamova T; Muelas N; Mongini T; Nafissi S; Claeys KG; Grewal RP; Takeuchi M; Hao H; Bönnemann C; Lopes Abath Neto O; Medne L; Brandsema J; Töpf A; Taneva A; Vilchez JJ; Tournev I; Haltiwanger RS; Takeuchi H; Jafar-Nejad H; Straub V; Paradas C
    Acta Neuropathol; 2020 Mar; 139(3):565-582. PubMed ID: 31897643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein O-Glucosyltransferase 1 Expression Influences Formation of Differentiated Myotubes in C2C12 Cell Line.
    Pélisse M; Der Vartanian A; Germot A; Maftah A
    DNA Cell Biol; 2018 Apr; 37(4):359-372. PubMed ID: 29634421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of MEGF10 deficiency on myoblast function and Notch1 interactions.
    Saha M; Mitsuhashi S; Jones MD; Manko K; Reddy HM; Bruels CC; Cho KA; Pacak CA; Draper I; Kang PB
    Hum Mol Genet; 2017 Aug; 26(15):2984-3000. PubMed ID: 28498977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three novel missense variants in two families with JAG2-associated limb-girdle muscular dystrophy.
    Dofash L; Lyengar K; Pereira N; Parmar J; Folland C; Laing N; Kang PB; Cairns A; Lynch M; Davis M; Ravenscroft G
    Neuromuscul Disord; 2024 Sep; 42():36-42. PubMed ID: 39121631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diseases related to Notch glycosylation.
    Matsumoto K; Luther KB; Haltiwanger RS
    Mol Aspects Med; 2021 Jun; 79():100938. PubMed ID: 33341260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megf10 deficiency impairs skeletal muscle stem cell migration and muscle regeneration.
    Li C; Vargas-Franco D; Saha M; Davis RM; Manko KA; Draper I; Pacak CA; Kang PB
    FEBS Open Bio; 2021 Jan; 11(1):114-123. PubMed ID: 33159715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-449a regulates insulin signalling by targeting the Notch ligand, Jag1 in skeletal muscle cells.
    Poddar S; Kesharwani D; Datta M
    Cell Commun Signal; 2019 Jul; 17(1):84. PubMed ID: 31345231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief report: Blockade of Notch signaling in muscle stem cells causes muscular dystrophic phenotype and impaired muscle regeneration.
    Lin S; Shen H; Jin B; Gu Y; Chen Z; Cao C; Hu C; Keller C; Pear WS; Wu L
    Stem Cells; 2013 Apr; 31(4):823-8. PubMed ID: 23307608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy.
    Saha M; Rizzo SA; Ramanathan M; Hightower RM; Santostefano KE; Terada N; Finkel RS; Berg JS; Chahin N; Pacak CA; Wagner RE; Alexander MS; Draper I; Kang PB
    Hum Mol Genet; 2019 Jul; 28(14):2365-2377. PubMed ID: 31267131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of Megf10/Drpr gain-of-function on muscle development in Drosophila.
    Draper I; Saha M; Stonebreaker H; Salomon RN; Matin B; Kang PB
    FEBS Lett; 2019 Apr; 593(7):680-696. PubMed ID: 30802937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease modeling and gene correction of LGMDR21 iPSCs elucidates the role of POGLUT1 in skeletal muscle maintenance, regeneration, and the satellite cell niche.
    Ortiz-Vitali JL; Wu J; Xu N; Shieh AW; Niknejad N; Takeuchi M; Paradas C; Lin C; Jafar-Nejad H; Haltiwanger RS; Wang SH; Darabi R
    Mol Ther Nucleic Acids; 2023 Sep; 33():683-697. PubMed ID: 37650119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells.
    Katoh M; Katoh M
    Int J Mol Med; 2006 Apr; 17(4):681-5. PubMed ID: 16525728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma.
    Fiaschetti G; Schroeder C; Castelletti D; Arcaro A; Westermann F; Baumgartner M; Shalaby T; Grotzer MA
    Acta Neuropathol Commun; 2014 Apr; 2():39. PubMed ID: 24708907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct biological roles for the notch ligands Jagged-1 and Jagged-2.
    Choi K; Ahn YH; Gibbons DL; Tran HT; Creighton CJ; Girard L; Minna JD; Qin FX; Kurie JM
    J Biol Chem; 2009 Jun; 284(26):17766-74. PubMed ID: 19398556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of notch signaling in duchenne muscular dystrophy.
    Den Hartog L; Asakura A
    Front Physiol; 2022; 13():984373. PubMed ID: 36237531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch ligands regulate the muscle stem-like state ex vivo but are not sufficient for retaining regenerative capacity.
    Sakai H; Fukuda S; Nakamura M; Uezumi A; Noguchi YT; Sato T; Morita M; Yamada H; Tsuchida K; Tajbakhsh S; Fukada SI
    PLoS One; 2017; 12(5):e0177516. PubMed ID: 28498863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.